2026年全球人工智慧（AI）視網膜篩檢設備市場報告

近年來，人工智慧（AI）視網膜篩檢設備市場發展迅速。預計該市場規模將從2025年的19.3億美元成長至2026年的21.8億美元，複合年成長率（CAGR）為13.1%。過去幾年成長要素包括：人工智慧眼科診斷技術的日益普及、糖尿病視網膜病變發病率的上升、對視網膜疾病早期檢測需求的成長、數位健康篩檢計畫的整合以及對預防性眼科保健日益重視。

預計未來幾年，人工智慧（AI）視網膜篩檢設備的市場規模將快速成長，到2030年將達到35.4億美元，複合年成長率（CAGR）為12.9%。預測期內的成長要素包括：自主AI篩檢系統的日益普及、視網膜診斷設備在臨床環境中的部署不斷擴大、政府對數位化眼科篩檢的支持力度加大、AI工具在遠距眼科實踐中的應用日益廣泛，以及對快速、低成本視網膜評估解決方案的需求不斷成長。預測期內的關鍵趨勢包括：用於視網膜影像分析的AI演算法的進步、基於邊緣運算的視網膜篩檢設備的創新、旨在提高影像擷取品質的技術發展、多模態眼科疾病檢測平台的研發，以及基於雲端的AI篩檢工作流程的改進。

糖尿病負擔的日益加重預計將推動人工智慧視網膜篩檢設備市場的成長。糖尿病是一種慢性代謝性疾病，其特徵是持續高血糖，長期高血糖會損害血管，包括為視網膜供血的血管，是全球可預防性視力喪失的主要原因之一。人口老化和生活方式的改變是導致糖尿病負擔加重的主要原因，這導致已開發國家和開發中國家的肥胖率上升和體力活動減少。人工智慧視網膜篩檢設備將透過早期發現糖尿病相關的視網膜損傷、擴大大規模篩檢的覆蓋範圍以及支持及時的臨床干預以預防視力喪失，從而有助於糖尿病管理。例如，根據總部位於比利時的世界衛生組織——國際糖尿病聯盟（IDF）的數據，到2024年，全球20至79歲的成年人中約有5.89億人患有糖尿病，預計到2050年，這一數字將達到8.53億。與過去幾十年相比，這是一個顯著的成長。因此，全球糖尿病負擔日益加重，推動了人工智慧視網膜篩檢設備市場的成長。

在人工智慧（AI）視網膜篩檢設備市場中，主要企業正致力於開發手持式AI眼底攝影機等先進產品，以改善就診途徑、加速診斷速度並實現疾病早期檢測。攜帶式AI眼底攝影機是一種攜帶式成像診斷設備，它利用人工智慧自動分析視網膜影像並檢測疾病徵兆。例如，2024年5月，美國食品藥物管理局Optomed USA Inc.推出了Optomed Aurora AEYE，這是首款獲得FDA核准的攜帶式AI眼底攝影機，用於檢測輕度至重度糖尿病視網膜病變。本設備具備AI驅動的自動影像分析功能，可在臨床環境中提供即時篩檢結果。這使得臨床決策無需專科醫生在場即可獲得支援。該設備採用電池供電，高度便攜，旨在擴大基層醫療、內分泌科和其他非專科機構的視力保護篩檢範圍。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球人工智慧視網膜篩檢設備市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 人工智慧（AI）和自主人工智慧
  • 生物技術、基因組學和精準醫療
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施、互聯生態系統
  • 工業4.0和智慧製造
• 主要趨勢
  • 疾病早期發現
  • 視網膜影像的自動分析
  • 整合遠距眼科護理
  • 眼部健康預測分析
  • 可擴展篩檢計劃

第5章 終端用戶產業市場分析

• 醫院
• 眼科診所
• 行動診所或當地醫療營地
• 診斷中心
• 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球人工智慧視網膜篩檢設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球人工智慧（AI）視網膜篩檢設備市場規模、對比及成長率分析
• 全球人工智慧視網膜篩檢設備市場表現：規模與成長，2020-2025年
• 全球人工智慧（AI）視網膜篩檢設備市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按組件
• 硬體、軟體、服務
• 透過技術
• 基於眼底影像的人工智慧（AI）、基於光學同調斷層掃描（OCT）的人工智慧（AI）、多模態人工智慧（AI）、機器學習（ML）、深度學習（DL）、自然語言處理（NLP）
• 不同的發展
• 基於雲端，本地部署
• 透過使用
• 糖尿病視網膜病變、老齡化黃斑部病變、青光眼、白內障及其他用途
• 最終用戶
• 醫院、眼科診所、行動診所或當地醫療營、診斷中心、研究機構和學術機構以及遠端醫療提供者。
• 按類型細分：硬體
• 醫療影像設備、感測器模組、顯示設備、儲存設備
• 按類型細分：軟體
• 影像處理軟體、診斷分析軟體、資料管理軟體、報表和視覺化軟體
• 按類型細分：服務
• 安裝和設定、維護和支援、培訓和教育以及諮詢服務。

第10章 區域與國別分析

• 全球人工智慧（AI）視網膜篩檢設備市場：按地區分類，實際結果和預測，2020-2025年、2025-2030年預測、2035年預測
• 全球人工智慧（AI）視網膜篩檢設備市場：按國家/地區分類，實際結果和預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 人工智慧（AI）視網膜篩檢設備市場：競爭格局及市場佔有率（2024年）
• 人工智慧（AI）視網膜篩檢設備市場：公司估值矩陣
• 人工智慧（AI）視網膜篩檢設備市場：公司概況
  • Carl Zeiss Meditec AG
  • Topcon Corporation
  • Canon Medical Systems Corporation
  • Bosch Healthcare Solutions GmbH
  • Heidelberg Engineering GmbH

第37章 其他大型企業和創新企業

• Shenzhen Sibionics Technology Co. Ltd., Digital Diagnostics Inc., Optomed Plc, Optain Health Inc., NIDEK Co. Ltd., Airdoc Technology Co. Ltd., Identifeye Health Ltd., Kowa Company Ltd., RetinaLyze System A/S, EyRIS Pte. Ltd., Eyenuk Inc., EYRIS Pte. Ltd., VUNO Inc., Eyenuk Inc., AEYE Health Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

• 2030年人工智慧（AI）視網膜篩檢設備市場：提供新機會的國家
• 2030年人工智慧（AI）視網膜篩檢設備市場：充滿新機會的細分市場
• 2030年人工智慧（AI）視網膜篩檢設備市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第41章附錄

An artificial intelligence (AI)-driven retinal screening device is a medical diagnostic system that integrates retinal imaging hardware with AI algorithms to automatically evaluate eye images and detect signs of retinal diseases. It facilitates early, accurate, and scalable identification of eye conditions, supporting timely clinical intervention and better patient outcomes.

The main components of AI-driven retinal screening devices are hardware, software, and services. Hardware includes retinal imaging devices such as fundus cameras and optical coherence tomography systems integrated with computing modules for image capture and analysis. Technologies used include fundus image-based AI, OCT-based AI, multimodal AI, machine learning, deep learning, and natural language processing. These solutions are deployed via cloud-based and on-premises models and applied in detecting diabetic retinopathy, age-related macular degeneration, glaucoma, cataract, and other conditions, serving hospitals, ophthalmology clinics, mobile clinics or rural camps, diagnostic centers, academic institutions, and telemedicine providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have impacted the ai-driven retinal screening device market by increasing the cost of importing high-precision imaging hardware and ai software components, creating delays in deployment, particularly in regions such as north america and europe which rely on imported devices. ophthalmology clinics, hospitals, and diagnostic centers are most affected, while the tariff has encouraged local manufacturing initiatives and innovation in cost-efficient ai solutions, providing a potential positive impact on domestic production capabilities.

The artificial intelligence (AI)-driven retinal screening device market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-driven retinal screening device market statistics, including artificial intelligence (AI)-driven retinal screening device industry global market size, regional shares, competitors with a artificial intelligence (AI)-driven retinal screening device market share, detailed artificial intelligence (AI)-driven retinal screening device market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-driven retinal screening device industry. This artificial intelligence (AI)-driven retinal screening device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-driven retinal screening device market size has grown rapidly in recent years. It will grow from $1.93 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increasing adoption of artificial intelligence (AI)-enabled ophthalmic diagnostics, growing incidence of diabetic retinopathy, rising demand for early retinal disease detection, increasing integration of digital health screening programs, and growing healthcare focus on preventive eye care.

The artificial intelligence (AI)-driven retinal screening device market size is expected to see rapid growth in the next few years. It will grow to $3.54 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to growing use of autonomous artificial intelligence (AI)-based screening systems, increasing deployment of point-of-care retinal devices, rising government support for digital eye screening initiatives, expanding integration of artificial intelligence (AI) tools in teleophthalmology, and increasing demand for rapid and low-cost retinal assessment solutions. Major trends in the forecast period include advancements in artificial intelligence (AI) algorithms for retinal image interpretation, innovations in edge-computing retinal screening devices, technology developments improving image acquisition quality, research and development in multimodal eye-disease detection platforms, and advancements in cloud-based artificial intelligence (AI) screening workflows.

The growing burden of diabetes is expected to propel the growth of the AI-driven retinal screening device market going forward. Diabetes is a chronic metabolic disease characterized by persistently high blood glucose levels that damage blood vessels over time, including those supplying the retina, and it is a leading cause of preventable vision loss worldwide. The rise in the diabetes burden is due to aging populations and lifestyle changes, which have increased obesity rates and reduced physical activity across both developed and developing regions. AI-driven retinal screening devices help in managing diabetes by enabling early detection of diabetes-related retinal damage, expanding screening access at scale, and supporting timely clinical intervention to prevent vision impairment. For instance, in April 2025, according to the International Diabetes Federation, a Belgium-based global health organization, approximately 589 million adults aged 20-79 were living with diabetes worldwide in 2024, with projections indicating that this number could rise to 853 million by 2050, showing a significant increase compared to previous decades. Therefore, the growing global burden of diabetes is driving the growth of the AI-driven retinal screening device market.

Leading companies operating in the artificial intelligence (AI)-driven retinal screening device market are focusing on developing advanced products, such as handheld AI fundus cameras, to boost accessibility, enhance diagnostic speed, and enable earlier disease detection. Handheld AI fundus cameras refer to portable imaging devices that use artificial intelligence to automatically analyze images of the retina for signs of disease. For instance, in May 2024, Optomed USA Inc., a US-based medical technology company, launched the Optomed Aurora AEYE. It is the first FDA-cleared, handheld AI fundus camera for the detection of more than mild diabetic retinopathy. The device features automatic, AI-based image analysis that provides an immediate screening result at the point of care, enabling clinical decision support without the need for a specialist to be present. It is battery-operated and highly portable, designed to increase access to sight-saving screenings in primary care, endocrinology, and other non-specialist settings.

In November 2025, Optain Health, a US-based healthcare technology company, acquired EyePACS for an undisclosed amount. This acquisition allows Optain Health to expand access to next-generation retinal imaging and AI-driven automated disease detection in primary care by integrating EyePACS's extensive teleophthalmology network with its AI-enabled imaging and screening technology, thereby enhancing early detection of ocular and systemic conditions at scale. EyePACS is a US-based healthcare technology company focused on AI-driven retinal screening and teleophthalmology solutions for early detection of eye diseases.

Major companies operating in the artificial intelligence (AI)-driven retinal screening device market are Carl Zeiss Meditec AG, Topcon Corporation, Canon Medical Systems Corporation, Bosch Healthcare Solutions GmbH, Heidelberg Engineering GmbH, Shenzhen Sibionics Technology Co. Ltd., Digital Diagnostics Inc., Optomed Plc, Optain Health Inc., NIDEK Co. Ltd., Airdoc Technology Co. Ltd., Identifeye Health Ltd., Kowa Company Ltd., RetinaLyze System A/S, EyRIS Pte. Ltd., Eyenuk Inc., EYRIS Pte. Ltd., VUNO Inc., Eyenuk Inc., AEYE Health Inc.

North America was the largest region in the artificial intelligence (AI)-driven retinal screening device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-driven retinal screening device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI)-driven retinal screening device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-driven retinal screening device market consists of revenues earned by entities by providing services such as automated retinal image analysis, diabetic retinopathy screening, glaucoma risk assessment, age-related macular degeneration detection, and tele-ophthalmology screening support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-driven retinal screening device market also includes sales of retinal imaging cameras, artificial intelligence software platforms, cloud-based diagnostic tools, handheld fundus imaging devices, and integrated screening systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Driven Retinal Screening Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai)-driven retinal screening device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-driven retinal screening device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-driven retinal screening device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Technology: Fundus Image-Based Artificial Intelligence (AI); Optical Coherence Tomography (OCT)-Based Artificial Intelligence (AI); Multi-Modal Artificial Intelligence (AI); Machine Learning (ML); Deep Learning (DL); Natural Language Processing (NLP)
• 3) By Deployment: Cloud-Based; On-Premise
• 4) By Application: Diabetic Retinopathy; Age-Related Macular Degeneration; Glaucoma; Cataract; Other Applications
• 5) By End-User: Hospitals; Ophthalmology Clinics; Mobile Clinics Or Rural Camps; Diagnostic Centers; Research And Academia; Telemedicine Providers
• Subsegments:
• 1) By Hardware: Imaging Devices; Sensor Modules; Display Units; Storage Devices
• 2) By Software: Image Processing Software; Diagnostic Analysis Software; Data Management Software; Reporting And Visualization Software
• 3) By Services: Installation And Setup; Maintenance And Support; Training And Education; Consulting Services
• Companies Mentioned: Carl Zeiss Meditec AG; Topcon Corporation; Canon Medical Systems Corporation; Bosch Healthcare Solutions GmbH; Heidelberg Engineering GmbH; Shenzhen Sibionics Technology Co. Ltd.; Digital Diagnostics Inc.; Optomed Plc; Optain Health Inc.; NIDEK Co. Ltd.; Airdoc Technology Co. Ltd.; Identifeye Health Ltd.; Kowa Company Ltd.; RetinaLyze System A/S; EyRIS Pte. Ltd.; Eyenuk Inc.; EYRIS Pte. Ltd.; VUNO Inc.; Eyenuk Inc.; AEYE Health Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Biotechnology, Genomics & Precision Medicine
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Early Disease Detection
  • 4.2.2 Automated Retinal Image Analysis
  • 4.2.3 Tele-Ophthalmology Integration
  • 4.2.4 Predictive Analytics For Eye Health
  • 4.2.5 Scalable Screening Programs

5. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ophthalmology Clinics
• 5.3 Mobile Clinics Or Rural Camps
• 5.4 Diagnostic Centers
• 5.5 Research And Academia

6. Artificial Intelligence (AI)-Driven Retinal Screening Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Artificial Intelligence (AI)-Driven Retinal Screening Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Segmentation

• 9.1. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hardware, Software, Services
• 9.2. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fundus Image-Based Artificial Intelligence (AI), Optical Coherence Tomography (OCT)-Based Artificial Intelligence (AI), Multi-Modal Artificial Intelligence (AI), Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP)
• 9.3. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cloud-Based, On-Premise
• 9.4. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diabetic Retinopathy, Age-Related Macular Degeneration, Glaucoma, Cataract, Other Applications
• 9.5. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ophthalmology Clinics, Mobile Clinics Or Rural Camps, Diagnostic Centers, Research And Academia, Telemedicine Providers
• 9.6. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Imaging Devices, Sensor Modules, Display Units, Storage Devices
• 9.7. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Image Processing Software, Diagnostic Analysis Software, Data Management Software, Reporting And Visualization Software
• 9.8. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Installation And Setup, Maintenance And Support, Training And Education, Consulting Services

10. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Regional And Country Analysis

• 10.1. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 11.1. Asia-Pacific Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 12.1. China Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 13.1. India Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 14.1. Japan Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 15.1. Australia Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 16.1. Indonesia Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 17.1. South Korea Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 18.1. Taiwan Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 19.1. South East Asia Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 20.1. Western Europe Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 21.1. UK Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 22.1. Germany Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 23.1. France Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 24.1. Italy Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 25.1. Spain Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 26.1. Eastern Europe Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 27.1. Russia Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 28.1. North America Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 29.1. USA Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 30.1. Canada Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 31.1. South America Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 32.1. Brazil Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 33.1. Middle East Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Intelligence (AI)-Driven Retinal Screening Device Market

• 34.1. Africa Artificial Intelligence (AI)-Driven Retinal Screening Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Artificial Intelligence (AI)-Driven Retinal Screening Device Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Regulatory and Investment Landscape

36. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Competitive Landscape And Company Profiles

• 36.1. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Artificial Intelligence (AI)-Driven Retinal Screening Device Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Company Profiles
  • 36.3.1. Carl Zeiss Meditec AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Topcon Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bosch Healthcare Solutions GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Heidelberg Engineering GmbH Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Intelligence (AI)-Driven Retinal Screening Device Market Other Major And Innovative Companies

• Shenzhen Sibionics Technology Co. Ltd., Digital Diagnostics Inc., Optomed Plc, Optain Health Inc., NIDEK Co. Ltd., Airdoc Technology Co. Ltd., Identifeye Health Ltd., Kowa Company Ltd., RetinaLyze System A/S, EyRIS Pte. Ltd., Eyenuk Inc., EYRIS Pte. Ltd., VUNO Inc., Eyenuk Inc., AEYE Health Inc.

38. Global Artificial Intelligence (AI)-Driven Retinal Screening Device Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Driven Retinal Screening Device Market

40. Artificial Intelligence (AI)-Driven Retinal Screening Device Market High Potential Countries, Segments and Strategies

• 40.1 Artificial Intelligence (AI)-Driven Retinal Screening Device Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Artificial Intelligence (AI)-Driven Retinal Screening Device Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Artificial Intelligence (AI)-Driven Retinal Screening Device Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer